This study is looking for ways to better identify and manage obstructive sleep apnea (OSA), a common sleep disorder. Researchers are studying tiny molecules called microRNAs in your blood to see if they can act as "biomarkers" for OSA. Biomarkers are like signals that can help doctors find OSA, check if treatments like Positive Airway Pressure (PAP) are working, and even predict how your blood pressure might respond to treatment. You could join if you are 18-75 years old and either have moderate-to-severe OSA and are willing to use PAP therapy, or if you do not have OSA. The study aims to see if microRNA levels change after 6 months of PAP treatment. The study is currently unclear on its recruitment status and plans to enroll 500 participants.

Study design

This is an observational study, meaning participants will be observed as part of their routine care. It aims to enroll 500 participants.

What's involved

If you have OSA, you would use Positive Airway Pressure (PAP) treatment as part of your routine clinical care. Blood samples will be taken at the start of the study and again after 6 months of PAP treatment, if applicable.

Compensation

Not stated in the trial record.

Follow-up

MicroRNA levels will be measured at the start of the study and after 6 months of PAP treatment, if applicable.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.